The Scenario: Staring at the 'Publications' Section
It is 11:47 PM on a Tuesday in August. You have your ERAS CV open on one monitor and your PubMed author page on the other.
One manuscript is accepted. DOI assigned. Page numbers pending. Real.
The other manuscript, the one you spent eight months on, the chart review that nearly broke you, is sitting in Editorial Manager status: "Under Review." Has been for 63 days.
And now the question that every competitive applicant hits at some point: Do I list it?
The pressure to look productive is immense. You see peers on Reddit listing four, five, six publications. Some look padded. You wonder if you should just write "Submitted to Nature Medicine" and call it a day.
Let me break this down specifically. Because what feels like a small formatting choice is actually a character test.
Program Directors do not read your research section. They scan it. Thirty seconds, often less. In that scan, they are running a binary filter. Is this real peer-reviewed science, or is this an applicant inflating their CV?
Submitted versus Accepted is not a spectrum. To a selection committee, it is a wall.
The Perception Gap: What 'Submitted' vs. 'Accepted' Actually Signals
Let us define terms like a reviewer would, not like a student hopes they mean.
Submitted means you uploaded a PDF. That is it. No editor has committed. No reviewer has validated the methods. The work exists, but it has zero external credibility. Anybody can submit anything.
Accepted means two or three strangers, who have no reason to like you, read your methods and said, "This meets the standard." Peer validation has occurred. The work crossed the finish line.
Here is the psychological gap I see year after year:
When you list a paper as "Submitted," you think you are signaling: I am active. I am producing.
What the PD reads is: Incomplete.
Subconsciously, "Submitted" puts you back in the idea phase. It signals potential, not execution. And residency selection is not rewarding potential in research. It is rewarding execution. Can this person start a project, endure revisions, and finish it while doing everything else?
An "Accepted" paper answers yes. Loudly.
An accepted paper tells me you understand ICMJE authorship criteria. You survived Reviewer 2. You responded to comments, re-ran a table, re-wrote a discussion. You navigated the most frustrating process in academic medicine and won.
That is academic maturity. Studies on selection criteria from internal medicine and surgical subspecialties consistently rank "peer-reviewed publications" as a top-tier marker for research aptitude. But when they drill down, they are talking about accepted or in-press work. Not submitted manuscripts.
The data inference is clear. An applicant with one accepted paper is consistently rated as more research-mature than an applicant with three "submitted" papers. One real thing beats three maybes. Every time.
The Lifecycle of a Manuscript: Navigating the Peer Review Lag
If you have ever submitted a manuscript in June hoping it will be accepted before ERAS opens in September, you have learned a painful lesson about academic time.
Academic time is not real time.
The average time from submission to first decision in clinical medicine is 4-6 weeks. Then revision: 3-4 weeks. Then re-review: another 3-4 weeks. Then acceptance, then proofing, then online publication. Three to six months is optimistic. Six to nine months is typical.
Your ERAS cycle is 90 days of pure chaos.
They are fundamentally mismatched. Which is why so many strong applicants get caught in this lag.
Let me give you the taxonomy that actually matters in the eyes of an experienced reviewer:
1. Submitted: In the portal. No decision. 2. Under Review / Under Revision: Actively in the peer review process. This is slightly stronger than Submitted, but still not validated. 3. Accepted: Acceptance letter received. DOI may not exist yet. 4. In Press / Epub Ahead of Print: Accepted and published online, but not yet assigned to a print issue. Functionally identical to Accepted. 5. Published: Print + online.
The sweet spot most students miss? In Press.
"In Press" is gold. If you have an acceptance email dated August 15th and ERAS opens September 4th, you do NOT list it as Accepted. You list it as "In Press" with the journal name and DOI if you have it. It shows momentum. It shows the paper escaped the black hole of peer review.
So what do you do if you are truly Under Review?
Here is my niche strategy, after reviewing hundreds of CVs for students applying to dermatology, orthopedics, and ENT where this distinction is lethal:
Do not list "Submitted" unless the journal is a top-tier journal in your specialty and the submission date is within the last 60 days. And even then, list it accurately as "Under Review at [Journal Name]" and only in a separate subsection titled "Manuscripts Under Review", NEVER in your primary "Peer-Reviewed Publications" section.
Mixing them pollutes the real publications. A PD sees three lines under Publications, starts reading, gets to the third and sees "(Submitted)", you have just forced them to discount the entire section by 30%.
The Data on Status: Why 'Accepted' Outweighs 'Submitted'
I am going to be direct here. For the current application cycle, only Accepted and In Press count.
Program Directors use two words behind closed doors when they talk about research entries: "real" and "not real." Real means I can verify it on PubMed today or on the journal website tomorrow. Not real means I have to trust the applicant.
You do not want a reviewer to have to trust you in the research section. You want them to verify you.
Listing a paper as "Submitted" when it is actually "Under Review" creates a discrepancy trap. Say you write "Submitted to Journal of the American Academy of Dermatology." The PD happens to be a reviewer for JAAD. She checks the system or asks a colleague. She finds out it is under revision elsewhere. Small lie? Probably not intentional. But now she is questioning your entire file. Accuracy matters more than volume.
And this is where In Press has a massive strategic advantage.
Data from academic medicine hiring shows that selection committees treat "In Press" with identical weight to "Published." Why? Because the decision is made. The peer review risk is gone. The paper is guaranteed to exist. For ERAS specifically, MyERAS even has a separate status option for "Accepted." It does not have one for "Submitted" in the peer-reviewed section for a reason.
The National Resident Matching Program data does not break down submitted vs accepted, but internal surveys of Program Directors tell the same story every year. When asked to rank what impresses them, PDs put "demonstrated ability to complete scholarly work" near the top. Completion is the keyword.
Incomplete perception is dangerous. I have seen applicants with zero accepted papers but two "submitted" manuscripts get passed over for interviews because the reviewer wrote, "Productive? Potentially. But no evidence of completion." That is a direct quote from a PD feedback session.
If your work is not accepted or in press by September 1st, it is strategically better to move it to a different part of your application entirely. List the research experience in your Work/Research Experiences section. Describe what you did, what you learned, and that a manuscript is currently under review. That shows activity without claiming a publication you do not yet have.
Do not contaminate your strongest section with your weakest entry.
Strategic CV Placement: Maximizing Your Research Section
Formatting is not decoration. Formatting is argument.
Here is how to structure a high-impact Research section that passes the 30-second scan.
Order matters. Ruthlessly.
- Peer-Reviewed Published / Accepted Publications: Numbered, reverse chronological. Bold your name.
- Peer-Reviewed In Press / Epub Ahead of Print: Right below it. Same formatting.
- Stop. Do not add a third subheader for Submitted within the Publications section.
If you must show under-review work, create a completely separate header at the bottom of your CV (after posters, presentations): "Manuscripts Under Peer Review." Use italics. Make it visually distinct. This tells the reader: I know the difference.
The Niche Detail:
For every Accepted paper, include: Authors (you bolded), Title, Journal (in italics), Year, Volume, Pages/DOI. And add the PMID if published. If you want to be elite, add Impact Factor in brackets only for high-impact journals in your field, e.g., J Am Acad Dermatol [IF 15.5]. Do not add impact factors for every low-tier journal. Looks insecure.
Example of a perfect entry:
Smith J., Doe A, Lee K. Efficacy of novel topical therapy for atopic dermatitis: a randomized controlled trial. J Am Acad Dermatol. 2024;91(2):310-318. doi:10.1016/j.jaad.2024.03.010. PMID: 38612345.
That entry is verifiable in 10 seconds. Trust goes up instantly.
Handling the Zero Scenario.
What if you have zero accepted papers? This is common. And not fatal.
Do not fake it by listing submitted papers as publications. That makes zero look worse.
Instead, you pivot.
In your Research Experiences section, you write: "Clinical Research Fellow, Dept. of Cardiology, [Institution]. Led retrospective analysis of 300 patients with heart failure with preserved ejection fraction. Led manuscript drafting; manuscript currently under review at JACC. Presented abstract at AHA 2024."
You have shown leadership, completion of work, and progression, without misrepresenting.
Real reviewers respect honesty about where you are in the process. They were once in the same lag.
Final point. Your research section has two jobs: be accurate and show completion.
Accuracy is non-negotiable. Completion is what interviewers remember. One accepted paper tells me you can finish. Three submitted manuscripts tell me you start things.
When you stare at that CV at midnight, ask yourself this simple question: If the PD emails the journal editor tomorrow morning, will my status hold up?
If the answer is no, take it off. Your credibility is worth more than one line item.
